Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/02/2003EP0929578B1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
05/02/2003EP0879294B1 Transduced human hematopoietic stem cells
05/02/2003EP0876397B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
05/02/2003EP0837871B1 Magnetic pigment
05/02/2003EP0835316B1 PHENYLACETYL-CoA LIGASE FROM PENICILLIUM CHRYSOGENUM
05/02/2003EP0802983B1 Expression of urokinase plasminogen activator inhibitors
05/02/2003EP0730653B1 Arabinoxylan degrading enzymes
05/02/2003EP0714435B1 Pro-urokinase mutants
05/02/2003EP0679190B1 Method for generating single-stranded dna molecules
05/02/2003EP0674710B1 Peptides with broad neoplastic specificity
05/02/2003EP0620858B1 Site-directed mutagenesis of dna
05/02/2003EP0603216B1 Biocidal proteins
05/02/2003EP0599971B1 Yeast promoter and use thereof
05/01/2003WO2003036257A2 Immobilizing biological molecules
05/01/2003WO2003035911A1 Clone identification by direct detection of nucleic acid binding proteins from vertebrate cell expression systems and applications thereof
05/01/2003WO2003035910A1 Transfection kinetics and structural promoters
05/01/2003WO2003035908A1 Method of detecting hereditary factors for hypertension
05/01/2003WO2003035904A2 Methods and compositions to evaluate antibody treatment response
05/01/2003WO2003035903A1 Method for isolating dna from biological samples
05/01/2003WO2003035895A2 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
05/01/2003WO2003035894A2 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
05/01/2003WO2003035892A2 Novel methods for introducing molecules into cells and vectors and compositions for use in such methods
05/01/2003WO2003035887A1 Selection of cells expressing heteromeric polypeptides
05/01/2003WO2003035884A2 Transient immortalization
05/01/2003WO2003035883A2 Methods and compositions for inducing tumor-specific cytotoxicity
05/01/2003WO2003035882A2 Novel expression system
05/01/2003WO2003035881A2 Stress tolerant plants
05/01/2003WO2003035880A2 Protein production with non-metabolizable expression inductor
05/01/2003WO2003035879A2 Promoters to control cell differentiation
05/01/2003WO2003035878A2 Lipase variants
05/01/2003WO2003035877A1 PROCESSES FOR PRODUCING β-1,3-N-ACETYLGLUCOSAMINE TRANSFERASE AND N-ACETYLGLUCOSAMINE-CONTAINING COMPOSITE SACCHARIDE
05/01/2003WO2003035876A1 Use of a double strand ribonucleic acid for treating an infection with a positive-strand rna-virus
05/01/2003WO2003035875A1 Method of elevating photosynthesis speed of plant by improving pyruvate phosphate dikinase
05/01/2003WO2003035874A1 Manipulation of starch granule size and number
05/01/2003WO2003035873A1 Novel glutamic acid receptor and utilization thereof
05/01/2003WO2003035872A1 Human and mammalian stem cell-derived neuronal survival polypeptides
05/01/2003WO2003035871A1 Promoter dna
05/01/2003WO2003035870A1 Drug for treating a carcinoma of the pancreas
05/01/2003WO2003035869A1 Use of a double-stranded ribonucleic acid for specifically inhibiting the expression of a given target gene
05/01/2003WO2003035868A1 Medicament that increases the effectiveness of a drug that induces receptor-mediated apoptosis in tumor cells
05/01/2003WO2003035867A1 Nucleic acid isolation method and apparatus for performing same
05/01/2003WO2003035866A1 Method of evaluating and identifying biologically functional molecule using marker gene
05/01/2003WO2003035864A1 Method of detecting target nucleic acid and nucleic acid probe
05/01/2003WO2003035863A1 Method of identifying prokaryotic gene structure
05/01/2003WO2003035862A2 Regulation of human arginase signature-containing protein
05/01/2003WO2003035861A2 Thrombin-cleavable chimeric proteins
05/01/2003WO2003035859A2 Regulation of human serine/threonine kinase
05/01/2003WO2003035858A2 Bacterial polypeptides involved in nucleic acid processing
05/01/2003WO2003035856A2 Protein with kinase activity
05/01/2003WO2003035853A1 Pig mast cell cultures and uses thereof
05/01/2003WO2003035849A2 Methods for gene transfer using pseudotyped lentiviruses
05/01/2003WO2003035848A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
05/01/2003WO2003035847A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003WO2003035843A2 Screening system for modulators of her2 mediated transcription and her2 modulators identifed thereby
05/01/2003WO2003035842A2 Hybridization control of sequence variation
05/01/2003WO2003035841A2 Methods and systems for dynamic gene expression profiling
05/01/2003WO2003035840A2 69583 and 85924, novel human protein kinase family members and uses therefor
05/01/2003WO2003035839A2 Target specific screening andits use for identifying target binders
05/01/2003WO2003035838A2 Stem cells that transform to beating cardiomyocytes
05/01/2003WO2003035837A2 Novel compositions and methods for cancer
05/01/2003WO2003035836A2 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
05/01/2003WO2003035835A2 Glycoprotein compositions
05/01/2003WO2003035834A2 Compositions and methods for making mutations in cell lines and animals
05/01/2003WO2003035829A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
05/01/2003WO2003035828A2 Method for cloning and expression of tspri restriction endonuclease and tspri methylase in e. coli
05/01/2003WO2003035826A2 Genetic screening methods
05/01/2003WO2003035697A1 Fusion peptide of human parathyroid hormone derived peptide and tat peptide, preparation thereof, and skin slimming cosmetic composition comprising the same
05/01/2003WO2003035696A2 Humanized antibodies against icam-1, their production and uses
05/01/2003WO2003035694A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003WO2003035693A2 Crystals of cytochrome p450 2c9, structures thereof and their use
05/01/2003WO2003035692A2 Modified peptides and their uses
05/01/2003WO2003035687A1 Nogo receptor homologues and their use
05/01/2003WO2003035685A1 Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy
05/01/2003WO2003035684A1 Ee3-protein family and corresponding dna sequences
05/01/2003WO2003035682A2 Peptides and protins binding to glu-pro motidfs, therapeutical compositions containing them and their applications
05/01/2003WO2003035681A2 Mycobacterial genes down-regulated during latency
05/01/2003WO2003035679A2 Molecules
05/01/2003WO2003035678A2 Sperm factor sequences
05/01/2003WO2003035677A2 Antimicrobial peptides from the venom of the spider cupiennius salei
05/01/2003WO2003035676A1 Groel chimeric protein and vaccine
05/01/2003WO2003035671A2 Methods for detecting genetic haplotypes by interaction with probes
05/01/2003WO2003035670A2 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
05/01/2003WO2003035667A2 Telomerase interference
05/01/2003WO2003035110A1 Treating vascular disease by inhibiting toll-like receptor-4
05/01/2003WO2003035083A1 Drug for treating a fibrotic disease through rna interfence
05/01/2003WO2003035082A1 Drug for inhibiting expression of a target gene
05/01/2003WO2003035048A2 Methods for the treatment of osteoarthritis and compositions thereof
05/01/2003WO2003035012A2 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
05/01/2003WO2003035010A2 Thymosin augmentation of genetic immunization
05/01/2003WO2003034985A2 Telomerase interference
05/01/2003WO2003034984A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003WO2003034903A2 Psma antibodies and protein multimers
05/01/2003WO2003034818A1 Sgrf genetically modified nonhuman animal
05/01/2003WO2003034814A1 Regulation of ethylene sensitivity during leaf and flower abscission
05/01/2003WO2003034813A2 Synthetic herbicide resistance gene
05/01/2003WO2003034812A2 Aromatic methyltransferases and uses thereof
05/01/2003WO2003034811A2 Method of improving crop yields
05/01/2003WO2003026409A3 Kv1.7 potassium channel disruptions, compositions and methods relating thereto
05/01/2003WO2003020985B1 Detection of genetic sequences using a bipartite probe
05/01/2003WO2003014363A8 Vector for site-specific integration of heterologous dna sequences into the rdn a sites of methylotrophic yeasts
1 ... 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 ... 4023